ClassID:

20291

A61K31/35 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Recent Application in this class:
#301
20140364476
2014-12-11

Cathepsin C inhibitors

#302
20140350093
2014-11-27

Methods of treating or preventing insulin resistance and associated diseases and conditions

#303
20140349919
2014-11-27

Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders

#304
20140341845
2014-11-20

Methods and systems for treating cell proliferation related disorders

#305
20140336248
2014-11-13

THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE

#306
20140329894
2014-11-06

Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease

#307
20140323399
2014-10-30

Compositions and methods for increasing insulin sensitivity

#308
20140322318
2014-10-30

Methods for administering weight loss medications

#309
20140315842
2014-10-23

Avermectins and milbemycins as anti-mycobacterial agents

#310
20140294950
2014-10-02

METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONS

#311
20140275618
2014-09-18

Therapeutic compounds and methods of use

#312
20140275173
2014-09-18

Oxabicyclo [2.2.2] acid GPR120 modulators

#313
20140248379
2014-09-04

Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts

#314
20140242035
2014-08-28

Methods and systems for treating cell proliferation disorders

#315
20140235707
2014-08-21

Methods and compositions for predicting response to eribulin

#316
20140200268
2014-07-17

Composition and method for treating dry eye syndrome

#317
20140187623
2014-07-03

Escalating dosing regimen for effecting weight loss and treating obesity

#318
20140187622
2014-07-03

Composition comprising coumestrol or a bean extract containing coumestrol

#319
20140187621
2014-07-03

COMPOSITION COMPRISING COUMESTROL OR A BEAN EXTRACT CONTAINING COUMESTROL

#320
20140187620
2014-07-03

COMPOSITION COMPRISING COUMESTROL OR A BEAN EXTRACT CONTAINING COUMESTROL

#321
20140187618
2014-07-03

COMPOSITIONS, METHODS AND KITS USING FOR INDUCING OR ENHANCING NEUROGENESIS IN CELLS AND TISSUE

#322
20140178509
2014-06-26

Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent

#323
20140170162
2014-06-19

PRESERVATION OF THE NEUROMUSCULAR JUNCTION (NMJ) AFTER TRAUMATIC NERVE INJURY

#324
20140161844
2014-06-12

Crosslinker enhanced repair of connective tissues

#325
20140154232
2014-06-05

Use of P13K Inhibitors for the Treatment of Obesity, Steatosis and ageing

#326
20140135387
2014-05-15

Use of equol for treating androgen mediated diseases

#327
20140088185
2014-03-27

METHOD OF TREATING DIGESTIVE UPSETS BY BUCCAL ADMINISTRATION OF BOTANICAL DERIVATIVES

#328
20140088168
2014-03-27

Anticonvulsant combination therapy

#329
20140088161
2014-03-27

Use of a feed composition for reducing methane emission in ruminants, and/or to improve ruminant performance

#330
20140065243
2014-03-06

Methods and compositions for treating cancer

#331
20140057862
2014-02-27

Formulations of histone deacetylase inhibitor and uses therof

#332
20140051653
2014-02-20

Topical application of ivermectin for the treatment of dermatological conditions/afflictions

#333
20140051623
2014-02-20

Bisphosphonate-prodrugs

#334
20140045692
2014-02-13

Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic

#335
20140039048
2014-02-06

Methods for the treatment of diabetic retinopathy and other ophthalmic diseases

#336
20140039045
2014-02-06

Composition of monoterpenoids having bactericidal properties

#337
20140037723
2014-02-06

Low dose topiramate/phentermine composition and methods of use thereof

#338
20140037685
2014-02-06

ADJUVANTS THAT ACTIVATE ADAPTIVE IMMUNE SYSTEM BY STIMULATING NLRP3

#339
20140031739
2014-01-30

Use of fusarochromanone and its derivatives in the diagnosis and treatment of cancer and other diseases

#340
20140031419
2014-01-30

Na/K-ATPase ligands, ouabain antagonists, assays and uses thereof

#341
20140018342
2014-01-16

Gamma secretase inhibitors

#342
20140011815
2014-01-09

Fitness assay and associated methods

#343
20130331413
2013-12-12

Defensin-like molecules as novel antimicrobial agents

#344
20130331408
2013-12-12

Opioid receptor ligands and methods of using and making same

#345
20130324584
2013-12-05

Cathepsin C inhibitors

#346
20130303474
2013-11-14

Composition for enhancing immunity containing compounds represented by chemical formulas 1-8 or sophora flavescens extract as active ingredient

#347
20130296416
2013-11-07

Selective inhibition of β1-adrenergic receptors for the treatment of pediatric heart failure

#348
20130289103
2013-10-31

Anti-microbial composition

#349
20130281525
2013-10-24

Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics

#350
20130281478
2013-10-24

Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression

#351
20130273160
2013-10-17

Methods and formulations for treating sialic acid deficiencies

#352
20130267502
2013-10-10

Treatment of addiction and impulse-control disorders using PDE7 inhibitors

#353
20130252925
2013-09-26

High concentration capsaicinoid pain relief composition

#354
20130251793
2013-09-26

PHARMACEUTICAL COMPOSITION COMPRISING PHENTERMINE AND TOPIRAMATE

#355
20130231492
2013-09-05

Flavone derivatives and their preparative method and medical use

#356
20130225513
2013-08-29

Methods and formulations for treating sialic acid deficiencies

#357
20130224272
2013-08-29

Compositions and methods for treating infestations

#358
20130217717
2013-08-22

Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound

#359
20130172282
2013-07-04

Method of treating herpes virus infection using macrocyclic lactone compound

#360
20130157985
2013-06-20

Pain relief compositions, manufacture and uses

#361
20130156784
2013-06-20

Compositions Using Antibodies Directed To GPNMB And Uses Thereof

#362
20130116337
2013-05-09

Methods and compositions for treating conditions mediated by oxidative stress or electrophilic environmental toxins

#363
20130096112
2013-04-18

Furo[3,2-g]chromene compounds and uses thereof

#364
20130090377
2013-04-11

COMPOSITION COMPRISING COUMESTROL OR A BEAN EXTRACT CONTAINING COUMESTROL

#365
20130071474
2013-03-21

COMBINATIONS OF BERBERINE, ARTEMISININ, Loperamide AND THEIR DERIVATIVES TO TREAT MALARIA, DIARRHEA, TRAVELERS' DIARRHEA, DYSENTERY, DENGUE FEVER, PARASITES, CHOLERA AND VIRUSES

#366
20130052263
2013-02-28

PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE

#367
20130041022
2013-02-14

Glyceollins Suppress Androgen-Responsive Prostate Cancer

#368
20130035382
2013-02-07

Iminochromene anti-viral compounds

#369
20130035302
2013-02-07

USE OF YESSOTOXIN AND ANALOGUES AND DERIVATIVES THEREOF FOR TREATING AND/OR PREVENTING NEURODEGENERATIVE DISEASES LINKED TO TAU AND BETA AMYLOID

#370
20130028921
2013-01-31

COMPOSITION COMPRISING COUMESTROL OR A BEAN EXTRACT CONTAINING COUMESTROL

#371
20130004575
2013-01-03

CONTROLLED RELEASE FORMULATIONS USING INTELLIGENT POLYMERS

#372
20120328593
2012-12-27

Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites

#373
20120322773
2012-12-20

MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS

#374
20120321609
2012-12-20

METHOD OF TREATING PSYCHOLOGICAL DISORDERS

#375
20120302630
2012-11-29

Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof

#376
20120283321
2012-11-08

USE OF GAMBIEROL FOR TREATING AND/OR PREVENTING NEURODEGENERATIVE DISEASES RELATED TO TAU AND BETA-AMYLOID

#377
20120282255
2012-11-08

METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCE

#378
20120277178
2012-11-01

Compositions and methods for treating fragile X premutation RVGG repeats-mediated toxicity

#379
20120276121
2012-11-01

Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases

#380
20120264821
2012-10-18

Use of equol for treating androgen mediated diseases

#381
20120264819
2012-10-18

Therapeutic uses of urolithins

#382
20120258062
2012-10-11

Topical application of ivermectin for the treatment of dermatological conditions/afflictions

#383
20120252885
2012-10-04

DRONABINOL TREATMENT FOR MIGRAINES

#384
20120251562
2012-10-04

Inhibitors of the PP1/GADD34 Complex for the Treatment of a Condition Requiring an Immunosuppressive Activity

#385
20120245181
2012-09-27

Opioid receptor ligands and methods of using and making same

#386
20120238614
2012-09-20

Anticonvulsant combination therapy

#387
20120238515
2012-09-20

Methods for preventing or treating sarcopenia and muscle atrophy in animals

#388
20120237598
2012-09-20

Anti-constipation composition

#389
20120232136
2012-09-13

Substance with sedative effect

#390
20120232000
2012-09-13

METHODS AND COMPOSITIONS FOR PROMOTING REGENERATION BY INCREASING INTRACELLULAR SODIUM CONCENTRATION

#391
20120220619
2012-08-30

Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease

#392
20120207688
2012-08-16

Rosacea Topical Skin Treatment Method and Formulation

#393
20120202288
2012-08-09

COMPOSITIONS COMPRISING CYCLIC AMP ENHANCERS AND/OR EP LIGANDS, AND METHODS OF PREPARING AND USING THE SAME

#394
20120201903
2012-08-09

CYTOPROTECTIVE OR THERAPEUTIC PLANT COMPOSITION

#395
20120184604
2012-07-19

Method for the treatment of bone diseases comprising colforsin daropate

#396
20120184554
2012-07-19

Therapeutic agent for mood disorders

#397
20120183632
2012-07-19

Pharmaceutical composition comprising an extract of and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

#398
20120172340
2012-07-05

Compositions and Methods for Selectively Activating Human Sirtuins

#399
20120129887
2012-05-24

COMPOUNDS DERIVED FROM ARTESUNATE, PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION AND USE OF THE RESPECTIVE MEDICINE

#400
20120128800
2012-05-24

Dietary supplements containing extracts of aronia and method of using same to promote weight loss

#401
20120122844
2012-05-17

Method of treating contrast-induced nephropathy

#402
20120121692
2012-05-17

COMPOUNDS AND COMPOSITIONS COMPRISING CDK INHIBITORS AND METHODS FOR TREATING CANCER

#403
20120115940
2012-05-10

Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis

#404
20120107300
2012-05-03

Cannabinoid Compositions and Methods

#405
20120101151
2012-04-26

Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease

#406
20120095088
2012-04-19

Medicinal cannabis uniform in food

#407
20120095063
2012-04-19

METHODS AND COMPOSITIONS FOR TREATMENT OF ISCHEMIC CONDITIONS AND CONDITIONS RELATED TO MITOCHONDRIAL FUNCTION

#408
20120093889
2012-04-19

Layered pharmaceutical formulations

#409
20120077766
2012-03-29

Topical application of ivermectin for the treatment of dermatological conditions/afflictions

#410
20120058157
2012-03-08

Methods of Treating Cardiovascular Disorders Associated with Atherosclerosis

#411
20120053235
2012-03-01

Dihydromyricetin as an IKK-beta inhibitor used for treatment of arthritis, cancer and autoimmune conditions, and other diseases or disorders

#412
20120046352
2012-02-23

Controlled decarboxylation

#413
20120046351
2012-02-23

Medicinal cannabis added in food

#414
20120046333
2012-02-23

Methods and Compositions of PI-3 Kinase Inhibitors for Treating Fibrosis

#415
20120046242
2012-02-23

MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY

#416
20120043242
2012-02-23

Medicinal cannabis fatty foodstuff

#417
20120041032
2012-02-16

Metalloprotein inhibitors

#418
20120035097
2012-02-09

Methods of treating bacterial infections using oritavancin

#419
20120022152
2012-01-26

Anti-constipation composition

#420
20120016016
2012-01-19

Methods and compositions for treating complications of diabetes and vascular diseases using flavones

#421
20120015053
2012-01-19

TREATMENT OF PSORIASIS

#422
20120015032
2012-01-19

COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME

#423
20120010232
2012-01-12

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

#424
20120003337
2012-01-05

HEALTH SUPPLEMENTS CONTAINING PHYTO-OESTROGENS, ANALOGUES OR METABOLITES THEREOF

#425
20120003312
2012-01-05

Multilayer Minitablets with Different Release Rates

#426
20110319484
2011-12-29

NEUROPROTECTIVE COMPOUNDS

#427
20110312925
2011-12-22

Methods of treating or preventing estrogen-related diseases

#428
20110312906
2011-12-22

TREATMENT OR REDUCTION OF MENOPAUSAL SYMPTOMS

#429
20110311624
2011-12-22

Formulations of histone deacetylase inhibitor and uses thereof

#430
20110306581
2011-12-15

Stable perfluorocarbon emulsion for use as an artificial oxygen carrier

#431
20110305782
2011-12-15

METHODS OF CHOLESTEROL REDUCTION USING ISOFLAVONES

#432
20110301078
2011-12-08

Prevention of bacterial growth and biofilm formation by ligands that act on cannabinoidergic systems

#433
20110300241
2011-12-08

Oral care compositions for treating xerostomia

#434
20110293691
2011-12-01

MULTIMODAL ADHESION BARRIER

#435
20110288161
2011-11-24

METHODS FOR TREATMENT OF THIOL-CONTAINING COMPOUND DEFICIENT CONDITIONS

#436
20110281855
2011-11-17

And potent tapentadol dosage forms

#437
20110275558
2011-11-10

Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders

#438
20110269715
2011-11-03

ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE

#439
20110262535
2011-10-27

Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof

#440
20110257138
2011-10-20

MONOTERPENES FOR TREATING RESPIRATORY TRACT DISEASES, IN PARTICULAR BRONCHOPULMONARY DISEASES

#441
20110257119
2011-10-20

Microcirculation improvement and/or treatment

#442
20110257118
2011-10-20

Vascular Circulation in Peripheral and/or Small Blood Vessels

#443
20110256150
2011-10-20

Modulation of axon degeneration

#444
20110251246
2011-10-13

Small molecule inhibitors of MUC1 and methods of identifying the same

#445
20110244057
2011-10-06

COMBINATION THERAPIES WITH TOPIRAMATE FOR SEIZURES, RESTLESS LEGS SYNDROME, AND OTHER NEUROLOGICAL CONDITIONS

#446
20110237662
2011-09-29

Method of treating inflammation with statins

#447
20110229941
2011-09-22

Gene cluster

#448
20110212171
2011-09-01

TASTE MASKED TOPIRAMATE COMPOSITION AND AN ORALLY DISINTEGRATING TABLET COMPRISING THE SAME

#449
20110207718
2011-08-25

COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS

#450
20110190229
2011-08-04

Compounds, compositions and methods for preventing skin darkening

#451
20110186518
2011-08-04

Polymer composition with phytochemical and dialysis membrane formed from the polymer composition

#452
20110184057
2011-07-28

PARENTERAL TREATMENT WITH STATINS

#453
20110178045
2011-07-21

Method to induce fatty liver in animal

#454
20110166217
2011-07-07

PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF BONE LOSS

#455
20110160298
2011-06-30

PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF BONE LOSS

#456
20110159005
2011-06-30

11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and uses thereof

#457
20110155130
2011-06-30

Dronabinol Treatment for Migraines

#458
20110144192
2011-06-16

Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria

#459
20110142950
2011-06-16

Polymer micelles containing anthracylines for the treatment of cancer

#460
20110136852
2011-06-09

Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease

#461
20110117070
2011-05-19

COMPOSITIONS AND METHODS FOR TREATING HEADACHE

#462
20110112181
2011-05-12

Polyphenol compounds with modulating neurotransmitter release

#463
20110110941
2011-05-12

Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic Agents

#464
20110104305
2011-05-05

COMPOUNDS AND METHODS FOR THIOL-CONTAINING COMPOUND EFFLUX AND CANCER TREATMENT

#465
20110104160
2011-05-05

Medicament for treatment cancer

#466
20110098289
2011-04-28

METHOD FOR TREATING OBESITY

#467
20110086023
2011-04-14

COMBINATION ANTIHISTAMINE MEDICATION

#468
20110082407
2011-04-07

Combination Therapies for the Treatment of Obesity

#469
20110065660
2011-03-17

Chemosensory receptor ligand-based therapies

#470
20110065138
2011-03-17

Quantitative Method For Detecting Yessotoxins In Fishery Products On Based On The Activation That The Toxin Produces In Cellular Phosphodiesterases And Therapeutic Use Of This Activation

#471
20110064711
2011-03-17

COMPOSITIONS CONTAINING COENZYME Q-10 AND AN ANTIOXIDANT

#472
20110059170
2011-03-10

Methods for administering weight loss medications

#473
20110053240
2011-03-03

DNA DAMAGING AGENTS IN COMBINATION WITH TYROSINE KINASE INHIBITORS

#474
20110044991
2011-02-24

METHODS AND COMPOSITIONS FOR TREATING LYMPHOMA AND MYELOMA

#475
20110038958
2011-02-17

Use of cannabinoids in combination with an anti-psychotic medicament

#476
20110038910
2011-02-17

ANTI-INFECTIVE ANTIMICROBIAL-CONTAINING BIOMATERIALS

#477
20110015663
2011-01-20

Combination Therapies for the Treatment of Obesity

#478
20110015158
2011-01-20

METALLOENZYME INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES

#479
20110003767
2011-01-06

Inhibitors of Acetyl-CoA Carboxylase for Treatment of Neuronal Hypometabolism

#480
20100324144
2010-12-23

Therapy for hyperexcitability disorders

#481
20100323955
2010-12-23

METHODS FOR TREATING OBESITY AND OBESITY RELATED DISEASES AND DISORDERS

#482
20100322952
2010-12-23

Compositions for and methods of enhancing the immune response to antigens

#483
20100317738
2010-12-16

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH NEURONAL DYSFUNCTION

#484
20100317731
2010-12-16

Hyperhidrosis treatment

#485
20100317730
2010-12-16

Treatment for menopausal and perimenopausal vasomotor symptons

#486
20100298422
2010-11-25

Polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same

#487
20100297109
2010-11-25

METHODS FOR INHIBITING FASCIN

#488
20100279978
2010-11-04

METHODS OF REDUCING THE SEVERITY OF MUCOSITIS

#489
20100273870
2010-10-28

Compositions and methods for treating infestations

#490
20100267643
2010-10-21

Chemosensory receptor ligand-based therapies

#491
20100266711
2010-10-21

THIENOBENZODIAZEPINE MODULATORS OF D1 RECEPTOR, D2 RECEPTOR, AND/OR 5-HT2 RECEPTOR

#492
20100260753
2010-10-14

AMINOFLAVONE (NSC 686288) AND COMBINATIONS THEREOF FOR TREATING BREAST CANCER

#493
20100249225
2010-09-30

C-(2-Phenyl-Cyclohexyl)-Methylamine Compounds for the Treatment of Anxiety Disorders

#494
20100249222
2010-09-30

Methods of treating skin with aromatic skin-active ingredients

#495
20100249165
2010-09-30

PDZ DOMAIN MODULATORS

#496
20100247501
2010-09-30

Foodstuff comprising an extract of a plant of the genus and flavonoid

#497
20100240576
2010-09-23

Anticonvulsant combination therapy

#498
20100239553
2010-09-23

Methods for promoting cellular health and treatment of cancer

#499
20100234413
2010-09-16

COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS

#500
20100234402
2010-09-16

METHODS AND COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY

#501
20100222422
2010-09-02

Dietary supplements containing extracts of aronia and methods of using same to promote weight loss

#502
20100222420
2010-09-02

Compositions and methods for inhibiting EZH2

#503
20100215739
2010-08-26

Low dose topiramate/phentermine composition and methods of use thereof

#504
20100215672
2010-08-26

Preparation process and utilization of Poncirus compositions having anti-allergic and antianaphylactic properties

#505
20100204312
2010-08-12

Methods and compositions for treating cancer

#506
20100196354
2010-08-05

Glutamate receptor antagonists and methods of use

#507
20100190793
2010-07-29

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

#508
20100189818
2010-07-29

Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical

#509
20100173952
2010-07-08

Metalloprotein inhibitors

#510
20100173013
2010-07-08

TREATMENT OF NEOPLASTIC DISORDERS USING COMBINATION THERAPIES

#511
20100160410
2010-06-24

USE OF PENTADIENOIC ACID DERIVATIVES FOR THE TREATMENT OF HYPERURICEMIA

#512
20100158973
2010-06-24

THERAPEUTIC USES OF CANNABIDIOL COMPOUNDS

#513
20100152125
2010-06-17

Compositions and methods for the diagnosis, treatment, and prevention of amyotrophic lateral sclerosis and related neurological diseases

#514
20100144859
2010-06-10

Dimeric avermectin and milbemycin derivatives

#515
20100144858
2010-06-10

Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator

#516
20100144855
2010-06-10

APPLICATION OF SEDOISOPROSAN FOR PREPARATION OF MEDICINE FOR TREATMENT OF HUMAN HBeAg POSITIVE CHRONIC HEPATITIS B

#517
20100137251
2010-06-03

Functional role for cannabinoids in autonomic stability during sleep

#518
20100113582
2010-05-06

Methods and compositions for treating HIV infections

#519
20100112088
2010-05-06

MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS

#520
20100112041
2010-05-06

Endoxifen compositions and methods

#521
20100105765
2010-04-29

Combination therapy for treatment of sleep apnea

#522
20100093845
2010-04-15

Composition and method for treating dry eye syndrome

#523
20100092579
2010-04-15

Medicament for treating lung cancer

#524
20100087519
2010-04-08

Use of equol for treating androgen mediated diseases

#525
20100087422
2010-04-08

Treatment of ADHD

#526
20100086599
2010-04-08

ORAL MODIFIED RELEASE FORMULATIONS

#527
20100075923
2010-03-25

Method of enhancing TGF-β signalling

#528
20100068313
2010-03-18

Cranberry seed oil extract and compositions containing components thereof

#529
20100063141
2010-03-11

Deuterated benzylbenzene derivatives and methods of use

#530
20100056560
2010-03-04

USE FOR TREATING OBESITY AND DIABETES

#531
20100048595
2010-02-25

USE OF ARCHAEA TO MODULATE THE NUTRIENT HARVESTING FUNCTIONS OF THE GASTROINTESTINAL MICROBIOTA

#532
20100041619
2010-02-18

Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders

#533
20100022634
2010-01-28

Laidlomycin compositions and methods

#534
20100016449
2010-01-21

Formulations with Improved Bioavailability

#535
20100016352
2010-01-21

COMPOUNDS AND METHODS FOR TREATING ESTROGEN RECEPTOR-RELATED DISEASES

#536
20100016249
2010-01-21

Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof

#537
20100010026
2010-01-14

Statin and omega-3 fatty acids for reduction of Apo-B levels

#538
20100004341
2010-01-07

-(2-phenyl-cyclohexyl)-methylamine compounds for therapy of fibromyalgia

#539
20090326057
2009-12-31

Therapeutic uses of urolithins

#540
20090324750
2009-12-31

Pharmaceutical composition comprising an extract of and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

#541
20090324715
2009-12-31

HIGH DOSE ORAL PHARMACEUTICAL COMPOSITIONS OF ARTEMETHER AND LUMEFANTRINE

#542
20090324580
2009-12-31

Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases

#543
20090304789
2009-12-10

NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERS

#544
20090304785
2009-12-10

Escalating dosing regimen for effecting weight loss and treating obesity

#545
20090298929
2009-12-03

NOVEL NATURAL CYCLODEXTRIN COMPLEXES

#546
20090292013
2009-11-26

In-Situ Forming Implant for Animals

#547
20090291976
2009-11-26

Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors

#548
20090286987
2009-11-19

Metalloprotein inhibitors

#549
20090285759
2009-11-19

DRUG, DRUG GUIDANCE SYSTEM, MAGNETIC DETECTION SYSTEM, AND DRUG DESIGN METHOD

#550
20090258941
2009-10-15

Use of fusarochromanone and its derivatives in the diagnosis and treatment of cancer and other diseases

#551
20090253675
2009-10-08

Pharmaceutical formulation

#552
20090252797
2009-10-08

Topical application of ivermectin for the treatment of dermatological conditions/afflictions

#553
20090241205
2009-09-24

METHOD FOR IDENTIFYING CRMP MODULATORS

#554
20090238882
2009-09-24

Carbon-substituted diketopiperazine delivery systems

#555
20090232853
2009-09-17

TREATMENT OF LAMINITIS

#556
20090227668
2009-09-10

Topical application of ivermectin for the treatment of dermatological conditions/afflictions

#557
20090227646
2009-09-10

Compositions Comprising Nebivolol

#558
20090227529
2009-09-10

Combination treatment for bladder cancer

#559
20090226551
2009-09-10

Pharmaceutical composition for prevention and/or treatment of bone loss

#560
20090226423
2009-09-10

Protein kinase C as a target for the treatment of respiratory syncytial virus

#561
20090221690
2009-09-03

Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof

#562
20090221620
2009-09-03

GENTIC POLYMORPHISMS ASSOCIATED WITH STROKE, METHODS OF DETECTION AND USES THEREOF

#563
20090215844
2009-08-27

Compositions Comprising Nebivolol

#564
20090214634
2009-08-27

COMPOSITIONS AND METHODS FOR THE TREATMENT OF BLADDER CANCER

#565
20090203678
2009-08-13

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PROTOZOAN PARASITIC DISEASES

#566
20090197939
2009-08-06

METHODS OF TREATING SKIN WITH AROMATIC SKIN-ACTIVE INGREDIENTS

#567
20090196918
2009-08-06

Liposomal formulations of hydrophobic lactone drugs in the presence of metal ions

#568
20090196917
2009-08-06

Liposomal Formulations of Hydrophobic Lactone Drugs in the Presence of Metal Ions

#569
20090192120
2009-07-30

INHIBITORS OF NITRIC OXIDE SYNTHASE

#570
20090191207
2009-07-30

Compositions and methods for the prophylaxis or treatment of viral diseases

#571
20090186091
2009-07-23

Methods of treating cardiovascular disorders associated with atherosclerosis

#572
20090182133
2009-07-16

BENZOPYRANONE DERIVATIVES AND THEIR USE AS ANTI-VIRAL AGENTS

#573
20090170788
2009-07-02

NOVEL USE OF 1, 2, 3, 4, 6-PENTA-O-GALLOYL-BETA-D-GLUCOSE

#574
20090163577
2009-06-25

METHODS AND COMPOSITIONS FOR ANTAGONIZING ANTI-APOPTOTIC Bcl-2-FAMILY PROTEINS

#575
20090162385
2009-06-25

Compositions for and methods of enhancing the immune response to antigens

#576
20090149530
2009-06-11

Antiinfective Flavonol Compounds and Methods of Use Thereof

#577
20090130128
2009-05-21

Antiinfective Proanthocyanidin Compounds and Methods of Use Thereof

#578
20090118358
2009-05-07

Kainate receptor-selective epimeric analogs of dysiherbaine

#579
20090110739
2009-04-30

Targeted cancer chemotherapy using synthetic nanoparticles

#580
20090104285
2009-04-23

Methods and Compositions for Use in Treating Cancer

#581
20090092624
2009-04-09

Antiinfective Flavononol Compounds and Methods of Use Thereof

#582
20090087441
2009-04-02

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

#583
20090076108
2009-03-19

METHOD FOR TREATING OBESITY

#584
20090061025
2009-03-05

Compositions and methods for treating infestations

#585
20090054384
2009-02-26

Airway alkalinization as therapy for airway diseases

#586
20090048315
2009-02-19

Method of alleviating chronic pain via peripheral glutaminase regulation

#587
20090048232
2009-02-19

Compositions and methods for prophylaxis and treatment of addictions

#588
20090042975
2009-02-12

Process For The Production Of Botanic Extracts

#589
20090041877
2009-02-12

COMPOSITION COMPRISING GROWTH FACTOR OF XANTHOCERAS SORBIFOLIA EXTRACTS, COMPOUNDS ISOLATED FROM SAME, METHODS FOR PREPARING SAME AND USES THEREOF

#590
20090036514
2009-02-05

Therapeutic effects of Bryostatins, Bryologs, and other related substances on Ischemia/stroke-induced memory impairment and brain injury

#591
20090031435
2009-01-29

SMA Therapy and Cell Based Assay

#592
20090022852
2009-01-22

Liquid Compositions Comprising Non-Digestible Oligosaccharides and Green Tea Catechins

#593
20090022794
2009-01-22

Topiramate Tablet Formulation

#594
20090012031
2009-01-08

EZH2 Cancer Markers

#595
20090010884
2009-01-08

PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION

#596
20090005305
2009-01-01

SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT TRANSLOCATION

#597
20080319042
2008-12-25

Compositions and methods for treatment of liver disease

#598
20080319036
2008-12-25

Method for treating obesity

#599
20080292720
2008-11-27

Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal

#600
20080292700
2008-11-27

CONTROLLED RELEASE FORMULATIONS USING INTELLIGENT POLYMERS